Life-changing Cell Therapies

Revolutionary Injectable Technology

RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.


Next-Gen Dermal Injection Technology
RCI-02 is a next-generation dermal injector designed to provide an improved level of control and precision for intradermal (dermis) and subcutaneous (extracellular matrix & fat) injections.
More About RCI-02